Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Lexaria Bioscience (LEXX) over the last 3 years, with Q4 2025 value amounting to $12.0.

  • Lexaria Bioscience's Interest & Investment Income rose 909.09% to $12.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $3018.0, marking a year-over-year decrease of 5690.42%. This contributed to the annual value of $3017.0 for FY2025, which is 7891.83% down from last year.
  • As of Q4 2025, Lexaria Bioscience's Interest & Investment Income stood at $12.0, which was up 909.09% from $2816.0 recorded in Q3 2025.
  • In the past 5 years, Lexaria Bioscience's Interest & Investment Income ranged from a high of $7319.0 in Q4 2023 and a low of -$1.0 during Q1 2024
  • Moreover, its 3-year median value for Interest & Investment Income was $190.0 (2025), whereas its average is $2477.1.
  • Per our database at Business Quant, Lexaria Bioscience's Interest & Investment Income tumbled by 9984.97% in 2024 and then soared by 909.09% in 2025.
  • Over the past 3 years, Lexaria Bioscience's Interest & Investment Income (Quarter) stood at $7319.0 in 2023, then tumbled by 99.85% to $11.0 in 2024, then rose by 9.09% to $12.0 in 2025.
  • Its last three reported values are $12.0 in Q4 2025, $2816.0 for Q3 2025, and $190.0 during Q2 2025.